Original Research
Accepted on 19 Jan 2024
IL-27 opposes neonatal BCG vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1217098
Type at least 3 characters
2,515 articles
Articles
Original Research
Accepted on 19 Jan 2024
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1338492
Review
Published on 19 Jan 2024
The uncharted territory of host-pathogen interaction in tuberculosis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1339467
Original Research
Published on 19 Jan 2024
Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1307546
Review
Accepted on 17 Jan 2024
The Next-generation DNA Vaccine Platforms and Delivery Systems: Advances, Challenges and Prospects
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1332939
Original Research
Published on 17 Jan 2024
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1235210
- 343 views
Original Research
Published on 16 Jan 2024
Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1335462
- 256 views
Original Research
Accepted on 15 Jan 2024
A SARS-CoV-2 RBD Vaccine Fused to the Chemokine MIP-3α Elicits Sustained Murine Antibody Responses over 12 Months and Enhanced Lung T Cell Responses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1292059
Original Research
Accepted on 15 Jan 2024
Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1330864
Original Research
Accepted on 12 Jan 2024
Sustained S-IgG and S-IgA Antibodies to Moderna's mRNA-1273 Vaccine in a Sub-Saharan African Cohort Suggests Need for the Vaccine Booster Timing Reconsiderations Sustained S-IgG and S-IgA Antibodies to Moderna's mRNA-1273 Vaccine in a Sub-Saharan African Cohort Suggests Need for Booster Timing Reconsiderations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1348905
- 124 views
Original Research
Accepted on 12 Jan 2024
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1346328
Original Research
Accepted on 12 Jan 2024
Age-dependent acquisition of IgG antibodies to Shigella serotypes -a retrospective analysis of sero-prevalence in Kenyan children with implications for infant vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1340425
Original Research
Published on 12 Jan 2024
Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne’s disease
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1307621
- 301 views
Original Research
Accepted on 11 Jan 2024
Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1327770
Systematic Review
Accepted on 10 Jan 2024
CAR Immunotherapy for the treatment of infectious diseases: A systematic review
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1289303
Brief Research Report
Accepted on 09 Jan 2024
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1338499
- 118 views